Proteolix Names Matthew Ferguson to Newly-Created Position of Chief Financi... ( SOUTH SAN FRANCISCO Calif. Feb. 2...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Proteolix Names Matthew Ferguson to Newly-Created Position of Chief Financial Officer

Date:2/25/2008

SOUTH SAN FRANCISCO, Calif., Feb. 25 /PRNewswire/ -- Proteolix, Inc., a clinical-stage company engaged in the development of novel pharmaceutical therapies for the treatment of cancer and immunological conditions, announced that it has appointed Matthew Ferguson to the new position of Chief Financial Officer. Mr. Ferguson brings extensive experience arranging financing and managing rapid growth in both life sciences and technology companies.

"We are delighted to have Matt on board as a key member of the Proteolix management team," said Susan Molineaux, Ph.D., the Company's President and CEO. "His experience building teams and infrastructure in high-growth environments and securing financing in both the private and public markets will serve Proteolix well as we continue to advance our clinical and research programs."

Before joining Proteolix, Mr. Ferguson served as CFO at medical device maker FoxHollow Technologies, Inc. During his five-year tenure there, the company advanced its flagship technology for the treatment of peripheral arterial disease through development, FDA approval and commercial launch in the U.S. Mr. Ferguson led FoxHollow's 2004 initial public offering and played a significant role in the company's 2007 merger with ev3 Inc. Mr. Ferguson previously held a variety of financial management and business development positions at ChannelPoint, Inc. and Hewlett-Packard. Mr. Ferguson holds an M.B.A. from the University of California at Berkeley and M.S. and B.S. degrees in engineering from the University of Pennsylvania and Stanford University, respectively.

"The Proteolix opportunity is driven by an expert team, a large unmet clinical need and compelling early clinical results for carfilzomib," commented Mr. Ferguson. "I look forward to contributing my skills and experience towards our dual goals of improving the lives of patients and generating substantial returns for our shareholders."

About Proteolix

Proteolix,
'/>"/>

SOURCE Proteolix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Proteolix Announces Clinical Results With Carfilzomib to be Reported at ASH 2007 Annual Meeting
2. Accident Fund Names General Agency Company its 2007 Agency of the Year
3. American Laser Centers Names Bill Van Huis as Chief Revenue Officer
4. Omron Healthcare Names New Chief Operating Officer Bob Kondraske
5. Birla Sun Life Insurance Names Quest Diagnostics its Exclusive Provider of Health Assessment Services in India
6. WeissComm Partners Names Tom Jones Managing Director to Deepen Global Product Communications Offering
7. Wyeth Consumer Healthcare Names New Head of Global R&D
8. Spectragenics Names Rpr Marketing Communications Agency of Record
9. Concentric Medical Names Kimberly Bridges as Vice President of Sales, Announces Receipt of $15 Million Growth Funding
10. Southern Research Institute Names Blaine Knight Vice President of Drug Discovery
11. CTG Names William D. McGuire a Director

Post Your Comments:

(Date:5/21/2013)... A new study appearing in the current ... cells harvested from fat (adipose) are more potent than ... the body’s immune system. , The finding could ... adipose tissue-derived stem cells (AT-SCs) are far more plentiful ... and can be collected from waste material from liposuction ...

(Date:5/21/2013)... Australia (PRWEB) May 22, 2013 About ... made the Fertility Clinics industry one of ... industry assists patients who are unable to conceive naturally ... and popular of which is in-vitro fertilisation (IVF) cycles. ... IVF cycles in Australia has increased by 4.4% per ...

(Date:5/21/2013)... in St. Louis announced today that it is ... by the Bill & Melinda Gates Foundation. Tae ... & chemical engineering, will pursue an innovative global ... of Parasite Eggs by Probiotic Organisms." , Grand ... ideas that can break the mold in how ...

(Date:5/21/2013)... Dayton, OH (PRWEB) May 21, 2013 ... is associated with an increased risk for CKD progression ... at Dayton Children’s Hospital and Johns Hopkins University has ... disease who are exposed to secondhand smoke. , ... years is the first study of the effect of ...

(Date:5/21/2013)... Columbia, MO (PRWEB) May 21, 2013 The ... 2,500 athletes and coaches from across the state to Columbia. ... campuses of the University of Missouri and Columbia College, and ... , The State Summer Games officially kick off at 7:30 ... Ceremony will feature a Go Wild! theme, the Parade of ...

Breaking Medicine News(10 mins):Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 2 Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 3 Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 2 Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 3 Health News:Gates Fellowship addresses parasite infection in developing world 2 Health News:Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study 2 Health News:Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study 3 Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 2 Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 3

[0] Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease [0] Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld [0] Gates Fellowship addresses parasite infection in developing world [0] Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study [0] Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia

... demands the immediate release of three Sri Lankan physicians whom the Sri ... ... (Vocus) May 18, 2009 -- Physicians for Human Rights (PHR) ... Lankan Army (SLA) detained on May 16, 2009. A Minister of Health ...

... (Nasdaq: BJGP ) ("BMP Sunstone" or the "Company"), today ... , Financial Highlights from the First Quarter Ended ... to $39.3 million from $18.1 million in, ... profit increased to $20.7 million from $7.7 million in the prior, ...

... 18 Beckman Coulter, Inc. (NYSE: BEC ... that simplify, automate and innovate complex biomedical testing, today ... of its common stock, to finance in part ... of Olympus Corporation,s Life Science business, or the acquisition. ...

... The Quigley Corporation, (Nasdaq: QG L ... , today announced an update on the Company,s ... announcement regarding the unexpected positive finding for its QR-333 ... 11b clinical trial. While the complete statistical results of ...

... suggests that evolution needed only a few genetic changes to ... comparing the fetal development of the eye of the owl ... only a minor difference in the timing of cell proliferation ... of eyes.The findings help scientists understand how a structure as ...

... Cincinnati (UC) cancer and cell biologists have identified a ... prostate cancers. , In a preclinical study ... that simultaneous inactivation of two particular genesknown as ... cancer tumors in mice. , "We knew that ...

Physicians for Human Rights Calls for the Release of Sri Lankan Doctors BMP Sunstone Reports First Quarter 2009 Financial Results Beckman Coulter, Inc. Announces Common Stock Offering The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure New Insight Into Primate Eye Evolution Research reveals molecular pathway behind invasive prostate cancers

(Date:5/21/2013)... May 21, 2013 Decision Resources, one ... firms for pharmaceutical and healthcare issues, finds ... on key efficacy endpoints, including overall survival ... most influence over surveyed U.S. and European ... positive, HER2-negative breast cancer. The two novel ...

(Date:5/21/2013)... , May 21, 2013 iHealth ... manufacture of wireless personal healthcare products and a ... reach, announcing the release of two new fitness ... pressure monitors and scales: the Wireless Pulse Oximeter ... (Photo: http://photos.prnewswire.com/prnh/20130521/SF17618 ) iHealth ...

(Date:5/21/2013)... FREDERICK, Md. , May 21, 2013 /PRNewswire/ ... inexpensive, disposable drug-free consumer electronic devices, announced that ... is presenting today to the FDA,s Medical Advisory ... reclassifying the company,s products for over the counter ... the FDA developed its medical device classification schema," ...

Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2 iHealth Lab adds new products and partners to mobile personal healthcare offering 2 iHealth Lab adds new products and partners to mobile personal healthcare offering 3 BioElectronics Presents FDA Reclassification Panel 2 BioElectronics Presents FDA Reclassification Panel 3

[0] Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer [0] iHealth Lab adds new products and partners to mobile personal healthcare offering [0] BioElectronics Presents FDA Reclassification Panel

... 26 Todd Bluedorn, chief executive officer of Lennox International ... at the J.P. Morgan HVAC Conference on Thursday, May 28 ... presentation materials can be accessed on the company,s website at ... archived for 60 days. The webcast can also be ...

... Health, Inc. (TH) is pleased to announce its involvement in ... Komen Foundation. TH,s collaborator, Duke University , was ... million of investment by the foundation in 2009 to further ... cancer.The Susan G. Komen for the Cure(R) is a nonprofit ...

Cached Medicine Technology:Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 2 Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 3

Lennox International to Present at J.P. Morgan Conference Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R)

MT-BT-5011-25 Prostate seeding needle (set of 25 unloaded needles).,MT-BT-5011-P Prostate seeding needle, pre-plugged and pre-sterilized, unloaded or for use with MEDTECs ASAP™ pre-load seedin...

... offers five classes of resectoscope electrodes ... loops, knife, roller bar & ball, ... only electrodes specifically integrated into the ... removal with minimal bleeding, increased visibility, ...

... and MRO™-2005 Rigid Percutaneous Nephroscopes combine ... throughput capacity with proven MRO performance. ... with small size sheaths. The MRO™-20 ... easy positioning during percutaneous procedures. The ...

... Resectoscope is based on the award winning ... the surgeon to perform TURis - resection ... element, HF cable and electrodes, Olympus OES ... in saline, supporting both, standard TUR and ...

Medicine Products:

MT-BT-5011 Prostate Seeding Needle USA Elite System™ & USA Series™ Roller Bar Electrode USA Elite System™ MRO™-20 Rigid Percutaneous Nephroscopes SurgMaster OES Pro Resectoscope